Blog

Upcoming webinar on “Overcoming Resistance” led by Michael Wick – The START Center for Cancer Research

Photo taken from events.zoom.us

Jun 14, 2024, 09:30

Upcoming webinar on “Overcoming Resistance” led by Michael Wick – The START Center for Cancer Research

The START Center for Cancer Research shared on LinkedIn: .

“Don’t miss our upcoming webinar, “Overcoming Resistance: Enhancing CDK4/6 Inhibitor Efficacy in Advanced Breast Cancer Treatment”, on July 9th at 3 PM ET.

Led by Michael Wick, Chief Scientific Officer at XenoSTART, this session will cover:
– Key insights into FDA-approved CDK4/6 inhibitors
– Mechanisms of resistance in ER+ breast cancer
– Strategies for re-sensitizing resistant patients through combination therapy

Source: The START Center for Cancer Research/LinkedIn

Advanced Breast Cancer cancer cancer treatment CDK4/6 inhibitors combination therapy ER+ breast cancer FDA approved Michael Wick OncoDaily Oncology resistant patients XenoSTART

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage